Sodium 4-aminosalicylate Dihydrate丨CAS 6018-19-5

Sodium 4-aminosalicylate Dihydrate丨CAS 6018-19-5
Product Introduction:
Catalog No.: SS124253
CAS No.: 6018-19-5
Assay: 99% min
Product Name: Sodium 4-aminosalicylate dihydrate
Molecular Formula: C7H6NNaO3.2(H2O)
Molecular Weight: 211.15
Synonym(s): 4-Aminosalicylic acid sodium salt dihydrate
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of sodium 4-aminosalicylate dihydrate丨cas 6018-19-5 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance: Off-white or light yellow powder
Assay: 99% min
Identification: Positive reaction
Solution color and clarity: Complies
Loss on drying: 16.0–17.5%
pH: 6.5–8.5
Chloride: 0.005%
Sulfate: 0.05% max
Heavy metal content: 10 ppm max
Fe: 15 ppm max
m-Aminophenol: 0.05% max

 

 

 

Applications

 

Sodium 4-aminosalicylate dihydrate is an important pharmaceutical compound primarily used as an antitubercular agent. It serves as the sodium salt form of para-aminosalicylic acid (PAS), which inhibits the synthesis of folic acid in Mycobacterium tuberculosis, thereby suppressing bacterial growth. It is typically employed as part of a combination therapy with other first- or second-line drugs such as isoniazid, rifampicin, and ethambutol to prevent the development of drug resistance. Beyond its antituberculosis role, it is also used in pharmaceutical research as a model compound to study drug metabolism, pharmacokinetics, and anti-inflammatory mechanisms. In certain formulations, it acts as a stabilizing and buffering agent due to its sodium salt form, which improves solubility and absorption characteristics.

 

Benefits

 

The dihydrate form of sodium 4-aminosalicylate provides enhanced chemical stability and better aqueous solubility compared to its free acid counterpart, allowing for more consistent bioavailability and reduced gastric irritation. It is well tolerated in most patients and contributes effectively to multi-drug regimens that limit the emergence of resistant tuberculosis strains. The compound exhibits both anti-inflammatory and antimicrobial properties, making it valuable in reducing inflammation in the gastrointestinal tract and respiratory tissues during infection. Its reliable efficacy, compatibility with other medications, and established safety record make it a trusted therapeutic agent in clinical practice.

 

Conclusion

 

Sodium 4-aminosalicylate dihydrate remains a vital component in the treatment of tuberculosis and related infections. Its dual antibacterial and anti-inflammatory properties, combined with excellent solubility, stability, and therapeutic compatibility, make it indispensable in modern multidrug therapies. The compound's pharmaceutical reliability continues to support global efforts in controlling and managing tuberculosis effectively.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us